期刊
NATURE REVIEWS DRUG DISCOVERY
卷 8, 期 10, 页码 783-793出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrd2959
关键词
-
资金
- National Institutes of Health [P01 AG09215, P30 AG10124, P01 AG11542, P01 AG14382, P01 AG14449, P01 AG17586, PO1 AG19724, P01 NS-044,233, UO1 AG24904]
- NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044233] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE ON AGING [P01AG019724, P01AG011542, P01AG009215, P01AG014382, U19AG010483, P30AG010124, P01AG017586, U01AG024904, P01AG014449] Funding Source: NIH RePORTER
Neuronal inclusions comprised of the microtubule-associated protein tau are found in numerous neurodegenerative diseases, commonly known as tauopathies. In Alzheimer's disease-the most prevalent tauopathy-misfolded tau is probably a key pathological agent. The recent failure of amyloid-beta-targeted therapeutics in Phase III clinical trials suggests that it is timely and prudent to consider alternative drug discovery strategies for Alzheimer's disease. Here, we focus on strategies directed at reducing misfolded tau and compensating for the loss of normal tau function.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据